Mannkind (MNKD) Free Cash Flow (2010 - 2026)
Mannkind (MNKD) reported Free Cash Flow of -$5.6 million for Q1 2026, up 16.03% year-over-year from -$4.9 million in Q1 2025, and up 27.35% quarter-over-quarter from -$7.8 million in Q4 2025.
Mannkind (MNKD) Free Cash Flow (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Free Cash Flow data on file, last reported at -$5.6 million in Q1 2026.
- Free Cash Flow for Q1 2026 came in at -$5.6 million, up 16.03% year-over-year; the trailing twelve-month figure through Mar 2026 was $18.7 million (down 11.22% YoY), and the FY2025 annual result was $17.6 million, down 46.26% from the prior year.
- Free Cash Flow rose to -$5.6 million in Q1 2026 per MNKD's latest filing, from -$7.8 million in the prior quarter.
- Over five years, Free Cash Flow peaked at $31.4 million in Q3 2023 and troughed at -$29.1 million in Q2 2022.
- A 5-year average of -$649588.2 and a median of -$1.3 million in 2023 frame the typical range for Free Cash Flow.
- On a YoY basis, Free Cash Flow climbed as much as 6427.5% in 2025 and fell as far as 233.18% in 2025.
- A 5-year view of Free Cash Flow shows it stood at -$8.5 million in 2022, then surged by 363.44% to $22.5 million in 2023, then sank by 35.77% to $14.4 million in 2024, then tumbled by 153.7% to -$7.8 million in 2025, then increased by 27.35% to -$5.6 million in 2026.
- Business Quant data shows MNKD's Free Cash Flow at -$5.6 million in Q1 2026, -$7.8 million in Q4 2025, and $24.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 63,220.27 |
| 10 | Mannkind | 1.21 Bn | 1.08 Bn | 82.66 Mn | -5.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.63 Mn |
| Mar 31, 2026 | -5.63 Mn |
| Dec 31, 2025 | -7.75 Mn |
| Dec 31, 2025 | -7.75 Mn |
| Sep 30, 2025 | 24.26 Mn |
| Sep 30, 2025 | 24.26 Mn |
| Jun 30, 2025 | 7.83 Mn |
| Jun 30, 2025 | 7.83 Mn |
| Mar 31, 2025 | -6.71 Mn |
| Mar 31, 2025 | -6.71 Mn |
| Dec 31, 2024 | 14.44 Mn |
| Dec 31, 2024 | 14.44 Mn |
| Sep 30, 2024 | 13.23 Mn |
| Sep 30, 2024 | 13.23 Mn |
| Jun 30, 2024 | 120,000.00 |
| Jun 30, 2024 | 120,000.00 |
| Mar 31, 2024 | 5.04 Mn |
| Mar 31, 2024 | 5.04 Mn |
| Dec 31, 2023 | 22.48 Mn |
| Dec 31, 2023 | 22.48 Mn |